Key Findings

• The review emphasizes evidence-based, holistic care for gender-questioning youth rather than a social justice model, calling for individualized assessments that screen for co-occurring conditions like autism and mental health issues.
• The evidence base for medical interventions—particularly puberty blockers and hormones—was found to be weak, prompting recommendations for a full research program and extreme caution, especially for hormones starting at age 16.
• A nominated medical practitioner should take overall clinical responsibility for patient safety, and every case for medical treatment must be reviewed by a national multidisciplinary team.
• Social transition decisions for pre-pubertal children should involve early consultation with experienced clinical professionals, reflecting a more cautious approach than previously standard.
• All children being considered for medical pathways must be offered fertility counseling and preservation before starting treatment.

Abstract

### **Aim of the Review** The primary goal of the Review is to make recommendations ensuring that children and young people who are questioning their gender identity or experiencing gender dysphoria receive a high standard of care. The focus is on providing care that meets their needs and is safe, holistic, and effective. ### **Context and Challenges** * **Surging Demand & Changing Demographics:** The NHS has seen an exponential growth in referrals and a marked change in the patient case-mix, which has overwhelmed the existing service model and led to unmanageably long waiting lists. * **Weak Evidence Base:** The Review found that the clinical approach has been operating on a remarkably weak evidence base, particularly concerning the use of puberty blockers and masculinising/feminising hormones. * **Polarized Environment:** The work was conducted amid a toxic, ideological, and polarized public debate, which has left many clinicians fearful of working with gender-questioning young people. ### **Approach** To navigate the conflicting views and weak existing data, the Review commissioned a robust and independent evidence review and research program from the University of York. This was intended to build a better evidence base for young people, their families, and clinicians. ### **Key Conclusions** * **Holistic and Individualized Care:** The care for this population must be holistic and personal, as these young people frequently have complex presentations, including high levels of neurodiversity and co-occurring mental health issues. Standard, evidence-based psychological treatments should be used to support their associated distress. * **Fluidity of Identity:** Young people's sense of identity is not always fixed and may evolve over time. While medical transition will be the best outcome for some, others may resolve their distress in different ways. * **Caution Regarding Medical Pathways:** Because the long-term health impacts of hormone interventions are limited and poorly understood, the Review advises extreme caution. Medical treatments, like puberty blockers, should be part of a rigorous research protocol. * **New Service Model:** The Review mandates a shift away from a single, highly specialized national service toward a distributed, regional network model. This aims to increase capacity, provide care closer to home, and ensure gender-questioning youth receive the same standard of holistic care as any other child or young person.

Summary

The Cass Review, published in April 2024, is an independent review of NHS gender identity services for children and young people that recommends a more cautious, evidence-based approach to care. It calls for holistic mental health assessments, improved research on medical interventions like puberty blockers and hormones, and stricter clinical oversight, while emphasizing that the review does not seek to undermine trans identities but rather ensure safe, effective care for a vulnerable and growing patient population.

Conclusion

The Cass Review concludes that children and young people questioning their gender identity or experiencing gender dysphoria require a high standard of care that is safe, holistic, and evidence-based. The Review found that the evidence base for medical interventions, particularly puberty blockers and masculinising/feminising hormones, is weak, and that clinical practice has been complicated by a toxic, polarised public debate. The ten key recommendations focus on: (1) ensuring services meet standard NHS care standards with clear clinical leadership; (2) implementing holistic assessment frameworks including screening for neurodevelopmental conditions and mental health; (3) using standard evidence-based psychological and psychopharmacological treatments; (4) ensuring early clinical involvement in decisions about social transition of pre-pubertal children; (5-6) establishing robust research and data collection programmes to improve the evidence base; (7) requiring long-standing gender incongruence as essential but not sufficient for medical treatment; (8) exercising extreme caution in prescribing hormones from age 16; (9) requiring national Multi Disciplinary Team review for all medical treatment cases; and (10) offering fertility counselling and preservation before any medical pathway. The Review emphasises that the NHS must work in an evidence-based way rather than following a social justice model, and that the needs of vulnerable children and young people must be prioritised over ideological positions.